Therapeutic Potential of Escherichia coli Nissle 1917 in Clinically Remission-attained Ulcerative Colitis Patients: A Hospital-based Cohort Study | Zendy

Gyu Man Oh | Zendy; Won Moon | Zendy; Kwang Il Seo | Zendy; Kyoungwon Jung | Zendy; Jae Hyun Kim | Zendy; Sung Eun Kim | Zendy; Moo In Park | Zendy; Seun Ja Park | Zendy

Open Access

Therapeutic Potential of Escherichia coli Nissle 1917 in Clinically Remission-attained Ulcerative Colitis Patients: A Hospital-based Cohort Study

Author(s) -

Gyu Man Oh,

Won Moon,

Kwang Il Seo,

Kyoungwon Jung,

Jae Hyun Kim,

Sung Eun Kim,

Moo In Park,

Seun Ja Park

Publication year - 2020

Publication title -

korean journal of gastroenterology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.203

H-Index - 25

eISSN - 2233-6869

pISSN - 1598-9992

DOI - 10.4166/kjg.2020.0119

Subject(s) - medicine , ulcerative colitis , cohort , gastroenterology , escherichia coli , cohort study , disease , biochemistry , chemistry , gene

Escherichia coli Nissle 1917 (EcN) alone therapy is as effective as mesalamine in inducing and maintaining remission in ulcerative colitis (UC). The efficacy and safety of EcN in combination with standard therapies have not been studied. This study examined the changes in the inflammation markers and symptoms following the additional administration of EcN to patients showing the clinical remission of UC.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research